Viral hepatitis refers to a group of infectious diseases that primarily affect the liver and are caused by various viruses, including hepatitis A, B, C, D, and E. These viruses exhibit different modes of transmission and clinical outcomes. Hepatitis A and E are typically transmitted through contaminated food and water, causing acute infections that do not lead to chronic liver disease. Hepatitis B, C, and D, on the other hand, are transmitted through blood or other bodily fluids, and they have the potential to lead to chronic infections, cirrhosis, and hepatocellular carcinoma. Preventive measures for hepatitis include vaccination for hepatitis A and B, practicing safe hygiene and sanitation, and implementing blood safety protocols. Antiviral medications are available for chronic hepatitis B and C infections, aiming to reduce the risk of complications. Global efforts focus on raising awareness, improving access to vaccination, and enhancing diagnostic and treatment options to combat the significant public health burden posed by viral hepatitis.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan